StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30106% above fair value
$54.99−3.20 (-5.50%)

Close on Nov 16, 2026Market cap $7.16BP/E –Yield –

10x Genomics gross margin

Gross margin is gross profit as a percentage of revenue.

10x Genomics's gross margin for the twelve months ending Sep 30, 2026 was 71.9%. For fiscal 2025 it was 69.1%, against 67.9% the year before. The highest annual figure on record is 85.1% in fiscal 2017.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202569.1%+1.2
FY2024Dec 31, 202467.9%+1.7
FY2023Dec 31, 202366.2%−10.5
FY2022Dec 31, 202276.7%−8.2
FY2021Dec 31, 202184.9%+4.5
FY2020Dec 31, 202080.4%+5.3
FY2019Dec 31, 201975.2%−5.2
FY2018Dec 31, 201880.4%−4.7
FY2017Dec 31, 201785.1%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202675.0%+7.6
Q2 FY2026Jun 30, 202674.5%+2.1
Q1 FY2026Mar 31, 202670.4%+2.3
Q4 FY2025Dec 31, 202568.1%+0.9
Q3 FY2025Sep 30, 202567.3%−2.8
Q2 FY2025Jun 30, 202572.3%+4.3
Q1 FY2025Mar 31, 202568.1%+2.2
Q4 FY2024Dec 31, 202467.2%+4.3
Q3 FY2024Sep 30, 202470.2%+8.0
Q2 FY2024Jun 30, 202468.1%+0.2
Q1 FY2024Mar 31, 202465.9%−7.4
Q4 FY2023Dec 31, 202362.9%−13.5
Q3 FY2023Sep 30, 202362.2%−14.6
Q2 FY2023Jun 30, 202367.8%−8.0
Q1 FY2023Mar 31, 202373.3%−4.5
Q4 FY2022Dec 31, 202276.4%−4.3
Q3 FY2022Sep 30, 202276.8%−3.6
Q2 FY2022Jun 30, 202275.8%−19.9
Q1 FY2022Mar 31, 202277.7%−6.1
Q4 FY2021Dec 31, 202180.8%−2.4
Q3 FY2021Sep 30, 202180.4%+0.5
Q2 FY2021Jun 30, 202195.8%+19.2
Q1 FY2021Mar 31, 202183.9%+4.9
Q4 FY2020Dec 31, 202083.2%+5.2
Q3 FY2020Sep 30, 202079.9%+5.2
Q2 FY2020Jun 30, 202076.6%+3.5
Q1 FY2020Mar 31, 202079.0%+5.1
Q4 FY2019Dec 31, 201978.0%+7.4
Q3 FY2019Sep 30, 201974.7%−11.0
Q2 FY2019Jun 30, 201973.1%−12.5
Q1 FY2019Mar 31, 201973.9%−11.6
Q4 FY2018Dec 31, 201870.5%–
Q3 FY2018Sep 30, 201885.7%–
Q2 FY2018Jun 30, 201885.7%–
Q1 FY2018Mar 31, 201885.5%–

More 10x Genomics figures

See a number that looks wrong?